View Author
cancer patient study family treatment prostate surveillance prostate cancer disease scale level health score distress netherland screening questionnaire survivor signi ficantly result carrier signi imiquimod response mutation member partner table quality hospital group advice follow-up lesion vulvar diagnosis genetic tumor individual university month prostate cancer survivors research number family members impact population sample status ficantly grade von hippel-lindau disease dutch support guideline variable 20 weeks range biopsy syndrome qlq-bn worry breast hrqol examination department 12 months lymphoma problem baseline control centre registry bene fits outcome profile analysis respondent vhl-related imiquimod treatment
10 Most Recent Publications
|
The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts
(Article)
Poll-Franse, L.V. van de Horevoorts, N. Mols, F. Eenbergen, M.V. Denollet, J. Roukema, J. Aaronson, N.K. Vingerhoets, A. Coebergh, J.W.W. Vries, J. de Essink-Bot, M.L.E. |
2011-09-01
|
|
Compliance with periodic surveillance for Von-Hippel-Lindau disease
(Article)
Lammens, C.R.M. Aaronson, N.K. Luijt, R.B. van der Ouweland, A.M.W. van den Hest, L.P. van Verhoef, S. Bleiker, E.M.A. Hes, F.J. Links, T.P. Zonnenberg, B.A. Lenders, J.W.M. Majoor-Krakauer, D.F. Os, T.A.M. van Gómez García, E.B. Herder, W.W. de |
2011-06-01
|
|
Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes
(Article)
Lammens, C.R.M. Bleiker, E.M.A. Luijt, R.B. van der Ouweland, A.M.W. van den Ruijs, M.W.G. Gundy, C. Nagtegaal, T. Aaronson, N.K. Verhoef, S. Ausems, M.G.E.M. Majoor-Krakauer, D.F. Sijmons, R.H. Hes, F.J. Gómez García, E.B. Os, T.A.M. van Spruijt, L. |
2011-06-01
|
|
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: Seven years median follow-up of a randomized clinical trial
(Article)
Terlou, A. Seters, M. van Ewing, P.C. Aaronson, N.K. Gundy, C.M. Heijmans-Antonissen, C. Quint, W.G.V. Blok, L.J. Beurden, M. van Helmerhorst, T.J.M. |
2011-04-01
|
|
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: Preliminary analysis of the results of the IMPACT study
(Article)
Mitra, A. Bancroft, E. Evans, D.G. Cruger, D. Blanco, I. Mercer, C. Kirk, J. Maehle, L. Hodgson, S. Walker, L. Izatt, L. Douglas, F. Barbachano, Y. Tucker, K. Dorkins, H. Clowes, V. Male, A. Donaldson, A. Brewer, C. Doherty, R. Bulman, B. Osther, P.J. Salinas, M. Page, E. Eccles, D. Axcrona, K. Jobson, I. Newcombe, B. Cybulski, C. Flesch-Janys, D. Buys, S.S. Townshend, S. Friedman, E. Domchek, S.M. Foster, C.S. Ramon Y Cajal, T. Spigelman, A. Teo, S.-H. Nicolai, N. Aaronson, N.K. Ardern-Jones, A. Bangma, C.H. Dearnaley, D. Eyfjord, J. Falconer, A. Jameson, C. Grönberg, H. Hamdy, F. Johannsson, O.T. Khoo, V. Kote-Jarai, Z. Lilja, H. Lubinski, J. Melia, J. Moynihan, C. Peock, S. Mitchell, G. Rennert, G. Schröder, F.H. Sibley, P. Suri, M. Wilson, P. Bignon, Y.-J. Strom, S. Tischkowitz, M. Liljegren, A. Ilencikova, D. Lindeman, G.J. Abele, A. Kyriacou, K. Asperen, C.J. van Kiemeney, L. Easton, D.F. Eeles, R. Stapleton, A. Suthers, G. |
2011-01-01
|
|
Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
(Article)
Lammens, C.R.M. Bleiker, E.M.A. Gómez García, E.B. Cats, A. Nagtegaal, T. Verhoef, S. Aaronson, N.K. Wagner, A. Sijmons, R.H. Ausems, M.G.E.M. Vriends, A.H.J.T. Ruijs, M.W.G. Os, T.A.M. van Spruijt, L. |
2010-12-01
|
|
Psychosocial impact of Von Hippel-Lindau disease: Levels and sources of distress
(Article)
Lammens, C.R.M. Bleiker, E.M.A. Hoogerbrugge, N. Gómez García, E.B. Dommering, C.J. Gundy, C.M. Aaronson, N.K. Verhoef, S. Hes, F.J. Ausems, M.G.E.M. Majoor-Krakauer, D.F. Sijmons, R.H. Luijt, R.B. van der Ouweland, A.M.W. van den Os, T.A.M. van |
2010-05-01
|
|
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
(Article)
Taphoorn, M.J. Claassens, L. Aaronson, N.K. Coens, C. Mauer, M. Osoba, D. Stupp, R. Mirimanoff, R.O. Bent, M.J. van den Bottomley, A. |
2010-04-01
|
|
Attitude towards pre-implantation genetic diagnosis for hereditary cancer
(Article)
Lammens, C.R.M. Bleiker, E.M.A. Spruijt, L. Verhoef, S. Gómez García, E.B. Ruijs, M.W.G. Aaronson, N.K. Vriends, A.H.J.T. Jansweijer, M. Ausems, M.G.E.M. Wagner, A. Sijmons, R.H. Ouweland, A.M.W. van den Luijt, R.B. van der |
2009-12-01
|
|
Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study
(Article)
Mols, F. Aquarius, A.E. Essink-Bot, M.L.E. Aaronson, N.K. Kil, P.J.M. Poll-Franse, L.V. van de |
2008-12-01
|
